BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35048405)

  • 21. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent metabolic reprogramming.
    Jin J; Qiu S; Wang P; Liang X; Huang F; Wu H; Zhang B; Zhang W; Tian X; Xu R; Shi H; Wu X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):377. PubMed ID: 31455352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR/HIF-1α/VEGF Signaling Pathway by Targeting CAB39.
    Nan Y; Guo H; Guo L; Wang L; Ren B; Yu K; Huang Q; Zhong Y
    Hum Gene Ther Clin Dev; 2018 Sep; 29(3):156-166. PubMed ID: 30180756
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Canagliflozin Modulates Hypoxia-Induced Metastasis, Angiogenesis and Glycolysis by Decreasing HIF-1α Protein Synthesis via AKT/mTOR Pathway.
    Luo J; Sun P; Zhang X; Lin G; Xin Q; Niu Y; Chen Y; Xu N; Zhang Y; Xie W
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anticancer Effects of γ-Tocotrienol Are Associated with a Suppression in Aerobic Glycolysis.
    Parajuli P; Tiwari RV; Sylvester PW
    Biol Pharm Bull; 2015; 38(9):1352-60. PubMed ID: 26328490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clk1-regulated aerobic glycolysis is involved in glioma chemoresistance.
    Zhang L; Yang H; Zhang W; Liang Z; Huang Q; Xu G; Zhen X; Zheng LT
    J Neurochem; 2017 Aug; 142(4):574-588. PubMed ID: 28581641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses in vitro angiogenesis through modulating the mTOR/HIF-1α/VEGF signaling axis in breast cancer cells.
    Pakravan K; Babashah S; Sadeghizadeh M; Mowla SJ; Mossahebi-Mohammadi M; Ataei F; Dana N; Javan M
    Cell Oncol (Dordr); 2017 Oct; 40(5):457-470. PubMed ID: 28741069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GPER-mediated stabilization of HIF-1α contributes to upregulated aerobic glycolysis in tamoxifen-resistant cells.
    Zhang Y; Song Y; Ren S; Zhang M; Zhang Z; Fan S; Liu X; Peng X; Qi Q; Shen X; Chen Y
    Oncogene; 2023 Jan; 42(3):184-197. PubMed ID: 36400971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of HIF-1α-mediated metabolic adaption by NRF2-silencing in breast cancer cells.
    Lee S; Hallis SP; Jung KA; Ryu D; Kwak MK
    Redox Biol; 2019 Jun; 24():101210. PubMed ID: 31078780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. mTORC1 drives HIF-1α and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3.
    Dodd KM; Yang J; Shen MH; Sampson JR; Tee AR
    Oncogene; 2015 Apr; 34(17):2239-50. PubMed ID: 24931163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indoleamine 2, 3-dioxygenase Up-regulates Hypoxia-inducible Factor-1α Expression by Degrading L-tryptophan but Not Its Activity in Human Alloreactive T-cells.
    Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):56-67. PubMed ID: 29512370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.
    Nardinocchi L; Puca R; D'Orazi G
    Aging (Albany NY); 2011 Jan; 3(1):33-43. PubMed ID: 21248371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vanillic Acid Suppresses HIF-1α Expression via Inhibition of mTOR/p70S6K/4E-BP1 and Raf/MEK/ERK Pathways in Human Colon Cancer HCT116 Cells.
    Gong J; Zhou S; Yang S
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53/Lactate dehydrogenase A axis negatively regulates aerobic glycolysis and tumor progression in breast cancer expressing wild-type p53.
    Zhou Y; Niu W; Luo Y; Li H; Xie Y; Wang H; Liu Y; Fan S; Li Z; Xiong W; Li X; Ren C; Tan M; Li G; Zhou M
    Cancer Sci; 2019 Mar; 110(3):939-949. PubMed ID: 30618169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
    Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
    Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A positive feedback circuit comprising p21 and HIF-1α aggravates hypoxia-induced radioresistance of glioblastoma by promoting Glut1/LDHA-mediated glycolysis.
    Jin X; Kuang Y; Li L; Li H; Zhao T; He Y; Di C; Kang J; Yuan L; Yu B; Li Q
    FASEB J; 2022 Mar; 36(3):e22229. PubMed ID: 35199870
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cucurbitacin B inhibits the translational expression of hypoxia-inducible factor-1α.
    Ma J; Zi Jiang Y; Shi H; Mi C; Li J; Xing Nan J; Wu X; Joon Lee J; Jin X
    Eur J Pharmacol; 2014 Jan; 723():46-54. PubMed ID: 24333213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulated phospholipase D2/mammalian target of rapamycin/hypoxia-inducible factor 1 alpha in peripheral T lymphocytes of oral lichen planus correlated with disease severity.
    Wang F; Zhang J; Zhou G
    Arch Oral Biol; 2019 Feb; 98():26-31. PubMed ID: 30419486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RIP140 inhibits glycolysis-dependent proliferation of breast cancer cells by regulating GLUT3 expression through transcriptional crosstalk between hypoxia induced factor and p53.
    Jacquier V; Gitenay D; Fritsch S; Bonnet S; Győrffy B; Jalaguier S; Linares LK; Cavaillès V; Teyssier C
    Cell Mol Life Sci; 2022 May; 79(5):270. PubMed ID: 35501580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking Mammalian Target of Rapamycin (mTOR) Attenuates HIF-1α Pathways Engaged-Vascular Endothelial Growth Factor (VEGF) in Diabetic Retinopathy.
    Wei J; Jiang H; Gao H; Wang G
    Cell Physiol Biochem; 2016; 40(6):1570-1577. PubMed ID: 27997905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RPS7 inhibits colorectal cancer growth via decreasing HIF-1α-mediated glycolysis.
    Zhang W; Tong D; Liu F; Li D; Li J; Cheng X; Wang Z
    Oncotarget; 2016 Feb; 7(5):5800-14. PubMed ID: 26735579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.